254 related articles for article (PubMed ID: 15370375)
1. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls.
Gilbert PE; Murphy C
J Clin Exp Neuropsychol; 2004 Sep; 26(6):779-94. PubMed ID: 15370375
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon4 genotype and gender: effects on memory.
Sundermann EE; Gilbert PE; Murphy C
Am J Geriatr Psychiatry; 2007 Oct; 15(10):869-78. PubMed ID: 17911364
[TBL] [Abstract][Full Text] [Related]
3. Differences between recognition memory and remote memory for olfactory and visual stimuli in nondemented elderly individuals genetically at risk for Alzheimer's disease.
Gilbert PE; Murphy C
Exp Gerontol; 2004 Mar; 39(3):433-41. PubMed ID: 15036403
[TBL] [Abstract][Full Text] [Related]
4. Olfaction in aging and Alzheimer's disease: event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE epsilon4+ and ApoE epsilon 4- individuals.
Murphy C; Solomon ES; Haase L; Wang M; Morgan CD
Ann N Y Acad Sci; 2009 Jul; 1170():647-57. PubMed ID: 19686207
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
6. Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease.
Gilbert PE; Barr PJ; Murphy C
J Int Neuropsychol Soc; 2004 Oct; 10(6):835-42. PubMed ID: 15637774
[TBL] [Abstract][Full Text] [Related]
7. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
Mayeux R; Small SA; Tang M; Tycko B; Stern Y
Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
[TBL] [Abstract][Full Text] [Related]
8. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL
Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
Bondi MW; Salmon DP; Galasko D; Thomas RG; Thal LJ
Psychol Aging; 1999 Jun; 14(2):295-303. PubMed ID: 10403716
[TBL] [Abstract][Full Text] [Related]
13. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
14. Patterns of brain activation in people at risk for Alzheimer's disease.
Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
[TBL] [Abstract][Full Text] [Related]
15. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
18. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
19. Preclinical memory profile in Alzheimer patients with and without allele APOE-epsilon4.
Estévez-González A; García-Sánchez C; Boltes A; Otermín P; Baiget M; Escartín A; del Rio E; Gironell A; Kulisevsky J
Eur Neurol; 2004; 51(4):199-205. PubMed ID: 15159600
[TBL] [Abstract][Full Text] [Related]
20. The domain-specific, stage-limited impact of the apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease.
Kim KW; Jhoo JH; Lee JH; Lee DY; Lee KU; Youn JC; Youn JY; Woo JI
Dement Geriatr Cogn Disord; 2002; 13(3):125-9. PubMed ID: 11893834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
